EVP R&D, Chief Medical Officer
Thu, Jan 8, 2026
Jan 8
5,000 shares @ $19.34
Increased holdings by +8.10%
54th largest trade (out of 152)
Trade made by an officer
10b5-1 scheduled trade
37% win rate · -4.7% median edge vs SPY (19 trades, 90-day · small sample)
Insider trade was 35% below market price